Exosome therapeutics for COVID‐19 and respiratory viruses
Abstract Respiratory viral diseases are a leading cause of mortality in humans. They have proven to drive pandemic risk due to their complex transmission factors and viral evolution. However, the slow production of effective antiviral drugs and vaccines allows for outbreaks of these diseases, emphas...
Main Authors: | Kristen D. Popowski, Phuong‐Uyen C. Dinh, Arianna George, Halle Lutz, Ke Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | View |
Subjects: | |
Online Access: | https://doi.org/10.1002/VIW.20200186 |
Similar Items
-
Exosome therapeutics for lung regenerative medicine
by: Kristen Popowski, et al.
Published: (2020-01-01) -
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia
by: Ali Akbari, et al.
Published: (2020-08-01) -
Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments
by: Sangiliyandi Gurunathan, et al.
Published: (2021-07-01) -
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
by: Atsunori Tsuchiya, et al.
Published: (2020-06-01) -
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
by: Sara Al-Khawaga, et al.
Published: (2020-10-01)